LSK BioPharma reports topline data from phase III study of rivoceranib in advanced gastric cancer June 28, 2019
Researchers link LIG3 mutations to mitochondrial neurogastrointestinal encephalomyopathy June 28, 2019
Phase I results for fluzoparib in combination with apatinib and paclitaxel in gastric cancer June 28, 2019